Arbutus Biopharma
ABUS
#6524
Rank
HK$5.82 B
Marketcap
HK$30.30
Share price
-5.60%
Change (1 day)
15.81%
Change (1 year)

EPS for Arbutus Biopharma (ABUS)

EPS in 2025 (TTM): -HK$2.02

According to Arbutus Biopharma 's latest financial reports the company's current EPS (TTM) is -HK$2.03. In 2024 the company made an earnings per share (EPS) of -HK$2.97 an increase over its 2023 EPS that were of -HK$3.44.

EPS history for Arbutus Biopharma from 1998 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$2.02-31.88%
2024-HK$2.97-13.64%
2023-HK$3.44-4.35%
2022-HK$3.59-44.58%
2021-HK$6.48-17%
2020-HK$7.81-65.4%
2019-HK$22.57138.84%
2018-HK$9.45-22.44%
2017-HK$12.18-78.45%
2016-HK$56.54424.64%
2015-HK$10.78-20.19%
2014-HK$13.5087.96%
2013-HK$7.18-142.59%
2012HK$16.87-342.7%
2011-HK$6.95-25.82%
2010-HK$9.3747.8%
2009-HK$6.34-43.55%
2008-HK$11.23158.91%
2007-HK$4.34-111.88%
2006HK$36.51-552.53%
2005-HK$8.07-71.77%
2004-HK$28.58-14.48%
2003-HK$33.42-8.95%
2002-HK$36.7170.07%
2001-HK$21.5848.01%
2000-HK$14.58-38.54%
1999-HK$23.72-24.6%
1998-HK$31.47

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Nymox Pharmaceutical
NYMX
-HK$0.47-76.92% Bahamas
NRC Health
NRC
HK$5.47-369.23%๐Ÿ‡บ๐Ÿ‡ธ USA